滚环扩增法无创产前筛查常见三体:前瞻性研究
本研究在3025名常规早孕期筛查孕妇中评估基于滚环复制与数字荧光检测、无需PCR或测序的cfDNA筛查21/18/13三体性能。2729例单胎随访者中2689例获有效结果,21三体灵敏度14/14(100%),18三体灵敏度1/2(50.0%),13三体未观察到确诊病例。结论对该法21三体与胎儿性别判定准确性高,但18/13三体例数少限制结论。
要点
- 21三体灵敏度100%(14/14),特异度99.7%,PPV 60.9%。
- 18三体灵敏度50.0%(1/2),PPV 14.3%,例数少。
- 未观察到确诊13三体病例,无法评价其性能。
核心结论
- 滚环复制法cfDNA筛查在非选择早孕期人群中21三体与胎儿性别判定准确性高。
- 18三体与13三体病例数少,限制了对这两种非整倍体的结论。
研究设计与样本
- 前瞻性研究,纳入3025名接受早孕期筛查的孕妇。
- 排除样本不可用、结局缺失、妊娠丢失及双胎后,2729例单胎有随访,2689例有cfDNA结果用于性能分析。
- cfDNA采用滚环复制与数字荧光检测,无需PCR或测序;性能以细胞遗传学结果或出生后结局确认。
主要发现
- 2729例中无效结果40例,总体无效率1.47%。
- 21三体:灵敏度14/14(100%;95%CI 76.8-100),特异度2666/2675(99.7%;95%CI 99.4-99.8),PPV 14/23(60.9%;95%CI 38.5-80.3)。
- 18三体:灵敏度1/2(50.0%;95%CI 1.3-98.7),特异度2681/2687(99.8%;95%CI 99.5-99.9),PPV 1/7(14.3%;95%CI 0.4-57.9)。
- 未观察到确诊13三体病例;胎儿性别正确判定2657/2688例(98.8%)。
- 孕10周前检测及IVF妊娠技术可行,但亚组例数少限制解释。
临床怎么用
- 该法可用于非选择早孕期人群的21三体筛查与胎儿性别判定。
- 对18三体与13三体性能因病例少尚不能定论,阳性结果需细胞遗传学确认。
局限性
- 18三体与13三体确诊病例数少,限制对这两种非整倍体的结论。
- 孕10周前与IVF亚组例数少,亚组发现受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate cell-free DNA screening for trisomies 21, 18 and 13 using rolling circle replication in an unselected routine first-trimester screening population. METHOD: This study enrolled 3025 women undergoing first-trimester screening. Excluding unavailable samples, missing outcome data, pregnancy loss and twin gestation, 2729 pregnancies with follow-up remained; 2689 had cell-free DNA results for performance analysis. Cell-free fetal DNA was assessed by rolling circle replication and digital fluorescence detection without PCR or sequencing. Performance was confirmed with cytogenetic results or postnatal outcomes. RESULTS: Among 2729 eligible singleton pregnancies with follow-up, valid cfDNA results were obtained in 2689 cases, corresponding to an overall no-call rate of 40/2729 (1.47%). For trisomy 21, sensitivity was 14/14 (100%; 95% CI, 76.8-100), specificity was 2666/2675 (99.7%; 95% CI, 99.4-99.8), and PPV was 14/23 (60.9%; 95% CI, 38.5-80.3). For trisomy 18, sensitivity was 1/2 (50.0%; 95% CI, 1.3-98.7), specificity was 2681/2687 (99.8%; 95% CI, 99.5-99.9), and PPV was 1/7 (14.3%; 95% CI, 0.4-57.9). No confirmed trisomy 13 cases were observed. Fetal sex was correctly assigned in 2657/2688 cases (98.8%). Testing before 10 weeks' gestation and in IVF pregnancies appeared technically feasible, but these subgroup findings were limited by small numbers. CONCLUSIONS: Rolling circle replication-based cell-free DNA screening showed high accuracy for trisomy 21 and fetal sex determination in this unselected routine first-trimester screening population. However, the small number of trisomy 18 and trisomy 13 cases limits conclusions for these aneuploidies.
引用
- Matallana CP, Romero JS, Pertegal M, et al. First-Trimester Cell-Free DNA Screening for Common Trisomies Using Rolling-Circle Amplification: A Prospective Study. Prenat Diagn. 2026. PMID: 42869439. doi:10.1002/pd.70260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。